Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Akoya Biosciences, Inc. (AKYA)  
$1.36 0.01 (0.74%) as of 4:30 Thu 7/3


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 37,110,000
Market Cap: 50.47(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.9457 - $3.24
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Akoya Biosciences is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. Spatial biology is an evolving technology that enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler™ and PhenoImager™ platforms, reagents, software and services, Co. provides solutions to perform tissue analysis and spatial phenotyping across the continuum from discovery through translational and clinical research.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 20,000
Total Buy Value $0 $0 $0 $92,014
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 0 0 0 60,000
Total Sell Value $0 $0 $0 $240,353
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 8
End Date 2025-04-03 2024-12-31 2024-07-02 2023-07-03

   
Records found: 106
  Page 1 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bamford Pascal Chief Clinical Officer   •       –      –    2025-06-01 4 D $1.25 $838 D/D (670) 205,738     -
   Ek John Frederick CFO   •       –      –    2025-04-01 4 D $1.35 $22,183 D/D (16,432) 248,202     -
   Ramachandran Niro Ph.d Chief Business Officer   •       –      –    2025-03-23 4 D $1.70 $3,927 D/D (2,310) 287,210     -
   Mckelligon Brian President and CEO   •       •      –    2025-03-23 4 D $1.70 $12,835 D/D (7,550) 420,126     -
   Ek John Frederick CFO   •       –      –    2025-03-01 4 D $1.63 $5,858 D/D (3,594) 264,634     -
   Bamford Pascal Chief Clinical Officer   •       –      –    2025-03-01 4 D $1.63 $6,276 D/D (3,850) 206,408     -
   Mckelligon Brian President and CEO   •       •      –    2025-03-01 4 D $1.63 $25,765 D/D (15,807) 427,676     -
   Kamocsay Jennifer Chief Legal Officer   •       –      –    2025-03-01 4 D $1.63 $12,135 D/D (7,445) 179,272     -
   Ramachandran Niro Ph.d Chief Business Officer   •       –      –    2025-03-01 4 D $1.63 $9,624 D/D (5,904) 289,520     -
   Kamocsay Jennifer Chief Legal Officer   •       –      –    2024-11-19 4 A $0.00 $0 D/D 87,500 186,717     -
   Mckelligon Brian President and CEO   •       •      –    2024-11-19 4 A $0.00 $0 D/D 218,750 443,483     -
   Bamford Pascal Chief Clinical Officer   •       –      –    2024-11-19 4 A $0.00 $0 D/D 87,500 210,258     -
   Ramachandran Niro Ph.d Chief Business Officer   •       –      –    2024-11-19 4 A $0.00 $0 D/D 87,500 295,424     -
   Ek John Frederick CFO   •       –      –    2024-11-19 4 A $0.00 $0 D/D 87,500 268,228     -
   Bamford Pascal Chief Clinical Officer   •       –      –    2024-08-29 4 A $0.00 $0 D/D 40,000 122,758     -
   Mckelligon Brian President and CEO   •       •      –    2024-06-11 4 AS $2.08 $15,630 D/D (7,500) 224,733 37%     
   Mckelligon Brian President and CEO   •       •      –    2024-06-11 4 OE $0.30 $2,273 D/D 7,500 232,233     -
   Mckelligon Brian President and CEO   •       •      –    2024-06-06 4 AS $2.01 $15,064 D/D (7,500) 224,733 53%     
   Mckelligon Brian President and CEO   •       •      –    2024-06-06 4 OE $0.30 $2,273 D/D 7,500 232,233     -
   Ek John Frederick CFO   •       –      –    2024-04-01 4 D $4.56 $65,080 D/D (14,272) 180,728     -
   Pla Frederic Chief Operating Officer   •       –      –    2024-03-23 4 D $4.79 $9,609 D/D (2,006) 101,500     -
   Ramachandran Niro Ph.d Chief Business Officer   •       –      –    2024-03-23 4 D $4.79 $9,609 D/D (2,006) 207,924     -
   Mckelligon Brian President and CEO   •       •      –    2024-03-23 4 D $4.79 $34,177 D/D (7,135) 224,733     -
   Mckelligon Brian President and CEO   •       •      –    2024-03-20 4 AS $4.97 $37,243 D/D (7,500) 231,868 -51%     
   Mckelligon Brian President and CEO   •       •      –    2024-03-20 4 OE $0.30 $2,273 D/D 7,500 239,368     -
  106 Records found
  1  2  3  4  5   
  Page 1 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us